Richard Watson

Richard Watson

Richard Watson is the director of clinical research at Tacoma, WA-based Revalesio.

Recent posts

Hitting the Target, Missing the Mark: How Targeted Therapies Have Left Patients Wanting
It is not unusual to read about another drug failure in a challenging neurological disease such as multiple sclerosis, Alzheimer’s disease, or Parkinson’s disease. Designing therapeutics with exquisite specificity has been... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
CMC in Drug Development and Life Cycle Management
PRA Health Sciences

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!